Company NPS Pharmaceuticals, Inc.
Equities
US62936P1030
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval | RE |
2015 | NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,581,155 | 108,074,845 ( 99.53 %) | 0 | 99.53 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- Stock
- Company NPS Pharmaceuticals, Inc.